|8.14||+0.2300||+2.91%||Vol 206.45K||1Y Perf 25.38%|
|Jun 21st, 2021 15:37 DELAYED|
|- -%||- -|
|Target Price||8.00||Analyst Rating||Strong Buy 1.00|
|Potential %||-2.20||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★ 38.98|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||☆ 23.41|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Market Cap||192.21M||Earnings Rating||—|
|Price Range Ratio 52W %||58.28||Earnings Date||24th Jun 2021|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||24th Jun 2021|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||219.55K|
|Avg. Monthly Volume||417.87K|
|Avg. Quarterly Volume||381.73K|
Aesthetic Medical International Holdings Group Ltd. (NASDAQ: AIH) stock closed at 7.91 per share at the end of the most recent trading day (a -2.94% change compared to the prior day closing price) with a volume of 210.04K shares and market capitalization of 192.21M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1550 people. Aesthetic Medical International Holdings Group Ltd. CEO is Zhou Pengwu.
The one-year performance of Aesthetic Medical International Holdings Group Ltd. stock is 25.38%, while year-to-date (YTD) performance is 50.09%. AIH stock has a five-year performance of %. Its 52-week range is between 3.81 and 11.24, which gives AIH stock a 52-week price range ratio of 58.28%
Aesthetic Medical International Holdings Group Ltd. currently has a PE ratio of -5.30, a price-to-book (PB) ratio of 3.34, a price-to-sale (PS) ratio of 1.63, a price to cashflow ratio of 11.50, a PEG ratio of 2.32, a ROA of -22.38%, a ROC of -21.11% and a ROE of -49.66%. The company’s profit margin is -20.04%, its EBITDA margin is -29.10%, and its revenue ttm is $125.17 Million , which makes it $5.30 revenue per share.
Of the last four earnings reports from Aesthetic Medical International Holdings Group Ltd., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Aesthetic Medical International Holdings Group Ltd.’s next earnings report date is 24th Jun 2021.
The consensus rating of Wall Street analysts for Aesthetic Medical International Holdings Group Ltd. is Strong Buy (1), with a target price of $8, which is -2.20% compared to the current price. The earnings rating for Aesthetic Medical International Holdings Group Ltd. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Aesthetic Medical International Holdings Group Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Aesthetic Medical International Holdings Group Ltd. has a Neutral technical analysis rating based on Technical Indicators (ADX : 29.41, ATR14 : 0.77, CCI20 : -65.00, Chaikin Money Flow : -0.06, MACD : 0.16, Money Flow Index : 55.01, ROC : -19.20, RSI : 48.14, STOCH (14,3) : 5.93, STOCH RSI : 0.00, UO : 37.69, Williams %R : -94.07), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Aesthetic Medical International Holdings Group Ltd. in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.